Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$3.26 - $4.84 $203,424 - $302,016
-62,400 Closed
0 $0
Q4 2020

Feb 03, 2021

SELL
$4.12 - $6.29 $40,788 - $62,271
-9,900 Reduced 13.69%
62,400 $257,000
Q3 2020

Nov 16, 2020

BUY
$4.82 - $8.77 $273,776 - $498,136
56,800 Added 366.45%
72,300 $391,000
Q2 2020

Aug 12, 2020

BUY
$2.83 - $6.99 $9,339 - $23,067
3,300 Added 27.05%
15,500 $104,000
Q1 2020

May 06, 2020

BUY
$3.18 - $7.0 $38,796 - $85,400
12,200 New
12,200 $39,000
Q3 2019

Nov 12, 2019

SELL
$2.8 - $3.99 $39,480 - $56,259
-14,100 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$2.34 - $4.28 $32,994 - $60,348
14,100 New
14,100 $54,000

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0

About RVL Pharmaceuticals plc


  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.